94 related articles for article (PubMed ID: 9332469)
1. Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers.
Ducharme MP; Bernstein ML; Granvil CP; Gehrcke B; Wainer IW
Cancer Chemother Pharmacol; 1997; 40(6):531-3. PubMed ID: 9332469
[TBL] [Abstract][Full Text] [Related]
2. The N-dechloroethylation of ifosfamide: using stereochemistry to obtain an accurate picture of a clinically relevant metabolic pathway.
Wainer IW; Ducharme J; Granvil CP
Cancer Chemother Pharmacol; 1996; 37(4):332-6. PubMed ID: 8548878
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients.
Granvil CP; Ducharme J; Leyland-Jones B; Trudeau M; Wainer IW
Cancer Chemother Pharmacol; 1996; 37(5):451-6. PubMed ID: 8599868
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.
Granvil CP; Madan A; Sharkawi M; Parkinson A; Wainer IW
Drug Metab Dispos; 1999 Apr; 27(4):533-41. PubMed ID: 10101149
[TBL] [Abstract][Full Text] [Related]
5. New insights into the pharmacokinetics and metabolism of (R,S)-ifosfamide in cancer patients using a population pharmacokinetic-metabolism model.
Di Marco MP; Wainer IW; Granvil CL; Batist G; Ducharme MP
Pharm Res; 2000 Jun; 17(6):645-52. PubMed ID: 10955835
[TBL] [Abstract][Full Text] [Related]
6. Determination of the enantiomers of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in plasma and urine using enantioselective gas chromatography with mass spectrometric detection.
Granville CP; Gehrcke B; König WA; Wainer IW
J Chromatogr; 1993 Dec; 622(1):21-31. PubMed ID: 8120109
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective induction of cyclophosphamide metabolism by phenytoin.
Williams ML; Wainer IW; Embree L; Barnett M; Granvil CL; Ducharme MP
Chirality; 1999; 11(7):569-74. PubMed ID: 10423284
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model.
Wainer IW; Granvil CP; Wang T; Batist G
Cancer Res; 1994 Aug; 54(16):4393-7. PubMed ID: 8044787
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of (R)- and (S)-cyclophosphamide and their dechloroethylated metabolites in cancer patients.
Williams ML; Wainer IW; Granvil CP; Gehrcke B; Bernstein ML; Ducharme MP
Chirality; 1999; 11(4):301-8. PubMed ID: 10224657
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, toxicity, pharmacokinetics, and in vitro metabolism of the enantiomers of ifosfamide in mice.
Masurel D; Houghton PJ; Young CL; Wainer IW
Cancer Res; 1990 Jan; 50(2):252-5. PubMed ID: 2295063
[TBL] [Abstract][Full Text] [Related]
11. The determination of (-)-(S)- and (+)-(R)-ifosfamide in plasma using enantioselective gas chromatography: a validated assay for pharmacokinetic and clinical studies.
Young CL; Frank H; Stewart CR; Wainer IW
Chirality; 1989; 1(3):235-8. PubMed ID: 2642052
[TBL] [Abstract][Full Text] [Related]
12. Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats.
Lu H; Wang JJ; Chan KK; Young D
Drug Metab Dispos; 1998 May; 26(5):476-82. PubMed ID: 9571229
[TBL] [Abstract][Full Text] [Related]
13. Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma.
Chugh R; Wagner T; Griffith KA; Taylor JM; Thomas DG; Worden FP; Leu KM; Zalupski MM; Baker LH
Cancer; 2007 Jun; 109(11):2315-22. PubMed ID: 17464949
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioavailability of stereoisomeric analogues of ifosfamide.
Sloderbach A; Hładoń B; Laskowska H
Acta Physiol Hung; 1996; 84(4):459-60. PubMed ID: 9328631
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective metabolism of ifosfamide by the kidney.
Aleksa K; Ito S; Koren G
Chirality; 2006 Jun; 18(6):398-405. PubMed ID: 16575879
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective pharmacokinetics of ifosfamide in male and female rats.
Wang JJ; Lu H; Chan KK
AAPS PharmSci; 2000; 2(2):E17. PubMed ID: 11741233
[TBL] [Abstract][Full Text] [Related]
17. Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450.
Chen CS; Jounaidi Y; Waxman DJ
Drug Metab Dispos; 2005 Sep; 33(9):1261-7. PubMed ID: 15919850
[TBL] [Abstract][Full Text] [Related]
18. A tubule cell model for ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
Can J Physiol Pharmacol; 2005 Jun; 83(6):499-508. PubMed ID: 16049550
[TBL] [Abstract][Full Text] [Related]
19. Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urine.
Kaijser GP; Beijnen JH; Bult A; Keizer HJ; Underberg WJ
J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):131-8. PubMed ID: 9106037
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of ifosfamide and its dechloroethylated and hydroxylated metabolites in children with malignant disease: a sparse sampling approach.
Kerbusch T; de Kraker J; Mathĵt RA; Beijnen JH
Clin Pharmacokinet; 2001; 40(8):615-25. PubMed ID: 11523727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
